EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Assessment of the pharmacodynamic properties of antimalarial drugs

Nicholas John White iD

Philosophical Transactions B · 30.04.2026 · 381 (1949)

DOI: 10.1098/rstb.2024.0339 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Philosophical Transactions B, online erschienen am 30.04.2026. Verfasst von Nicholas John White. Beteiligte Einrichtung: Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Malaria, Falciparum. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantifying therapeutic responses in clinical malaria is easier than for most other infections as the intraerythrocytic parasites can be counted by microscopy or estimated using quantitative PCR. In treating the blood-stage of malaria, between 107 and 1013 parasites undergo a first-order decline in densities at a rate determined by the concentrations and potency of the antimalarial drug. A simple conceptual framework based on total intravascular parasite biomass and standard sigmoid concentration–effect relationships for parasite killing explains most, but not all, aspects of antimalarial therapeutic responses, and it has proved very useful in designing chemoprevention and treatment regimens and in understanding the selection and spread of resistance. Drugs acting on younger circulating ring-stage asexual parasites (artemisinins, cipargamin, ganaplacide) provide rapid parasite clearance, which translates into faster clinical recoveries and a life-saving benefit in severe malaria. Artemisinin-sensitive Plasmodium falciparum densities decline with a half-life (PC1/2) of usually less than 5 h. Many antimalarial drugs are eliminated slowly and provide protracted exposures, which allows full treatment to be administered in 3 days, and also provides chemosuppression of newly acquired infections for 1 month. Greater availability of drug measurement in malaria-endemic areas would facilitate the field assessment of antimalarial drugs. This article is part of the Theo Murphy meeting issue ‘Evaluating anti-infective drugs’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium falciparumMalaria, FalciparumHumansAnimalsDrug Resistance

Stichwörter der Autor:innen

antimalarialsmalariapharmacodynamicspharmacometrics

Substanzen

Antimalarials

Autor:innen und Institutionen

  • Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK.

ORCID-Profile: Nicholas John White

Förderung

  • Wellcome

Zitieren

APA

White, N. J. (2026). Assessment of the pharmacodynamic properties of antimalarial drugs. Philosophical Transactions B, 381(1949). https://doi.org/10.1098/rstb.2024.0339

Vancouver

White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs. Philosophical Transactions B. 2026;381(1949). doi:10.1098/rstb.2024.0339

BibTeX
@article{White2026,
  author = {White, Nicholas John},
  title = {Assessment of the pharmacodynamic properties of antimalarial drugs},
  journal = {Philosophical Transactions B},
  year = {2026},
  volume = {381},
  number = {1949},
  doi = {10.1098/rstb.2024.0339}
}
Kostenlos starten →